In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sean Werner, Chief Technology Officer at BioLife Solutions,

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sean, covering:

The value of learning your craft in big pharma, and the steep transition from technical expert to President of a spinout
Why BioLife moved from board involvement to acquiring Sean’s company outright
The critical role of cryopreservation, and why it remains an overlooked risk in cell therapy development
His perspective on the cell and gene therapy space, and why there is still plenty of reason for optimism
The rise of China’s biotech ecosystem and why its growth is a positive for the global industry
Why CGT is set to diverge into more specialised areas, unlocking new therapeutic and patient applications

Sean Werner is the Chief Technology Officer at BioLife Solutions, a leading provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. BioLife acquired Sexton Biotechnologies in 2021 where Sean was President of the company known for providing processing and handling solutions for the CGT industry. Sean received his PhD from Purdue University in Biology followed by post-doctoral positions at the Indiana University School of Medicine and Eli Lilly. Sean has previous experience filling various roles in the scientific, global regulatory, and general management functions supporting medical devices, autologous cell therapy, and single use disposable development programs. In his 23 years working in the life science industry, he has guided regenerative medicine research programs, pre-clinical and clinical testing and submission strategies leading to global commercialization of medical devices and bioprocessing tools and successful initiation of multi-national cell therapy clinical studies.

Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!